GF Fund Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8K Hold
1,036
﹤0.01% 535
2025
Q1
$10.6K Buy
1,036
+192
+23% +$1.96K ﹤0.01% 558
2024
Q4
$13.4K Buy
+844
New +$13.4K ﹤0.01% 511